The metabolic syndrome and stroke -: Potential treatment approaches

[1] Population comparison of two clinical approaches to the metabolic syndrome - Implications of the new International Diabetes Federation consensus definition [J]. DIABETES CARE, 2005, 28 (11) : 2777 - 2779

[2] The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 9047 - 9054

[3] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480

[4] High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis [J]. NEUROLOGY, 2004, 63 (01) : 27 - 32

[5] Arenillas Juan F, 2005, Cerebrovasc Dis, V20 Suppl 2, P75, DOI 10.1159/000089359

[6] Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness [J]. ATHEROSCLEROSIS, 2003, 171 (02) : 303 - 309

[7] Association of the metabolic syndrome with intracranial atherosclerotic stroke [J]. NEUROLOGY, 2005, 65 (02) : 296 - 298

[8] Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J]. NATURE, 1999, 402 (6764) : 880 - 883

[9] Adipose tissue, inflammation, and cardiovascular disease [J]. CIRCULATION RESEARCH, 2005, 96 (09) : 939 - 949

[10] Increased plasma levels of 15-deoxy Δ prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke [J]. STROKE, 2005, 36 (06) : 1189 - 1194

[1] Population comparison of two clinical approaches to the metabolic syndrome - Implications of the new International Diabetes Federation consensus definition [J]. DIABETES CARE, 2005, 28 (11) : 2777 - 2779

[2] The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 9047 - 9054

[3] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480

[4] High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis [J]. NEUROLOGY, 2004, 63 (01) : 27 - 32

[5] Arenillas Juan F, 2005, Cerebrovasc Dis, V20 Suppl 2, P75, DOI 10.1159/000089359

[6] Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness [J]. ATHEROSCLEROSIS, 2003, 171 (02) : 303 - 309

[7] Association of the metabolic syndrome with intracranial atherosclerotic stroke [J]. NEUROLOGY, 2005, 65 (02) : 296 - 298

[8] Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J]. NATURE, 1999, 402 (6764) : 880 - 883

[9] Adipose tissue, inflammation, and cardiovascular disease [J]. CIRCULATION RESEARCH, 2005, 96 (09) : 939 - 949

[10] Increased plasma levels of 15-deoxy Δ prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke [J]. STROKE, 2005, 36 (06) : 1189 - 1194